406 related articles for article (PubMed ID: 28724760)
41. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
42. KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.
Sharma S; Munger K
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269126
[TBL] [Abstract][Full Text] [Related]
43. The Asian-American variant of human papillomavirus type 16 exhibits higher activation of MAPK and PI3K/AKT signaling pathways, transformation, migration and invasion of primary human keratinocytes.
Hochmann J; Sobrinho JS; Villa LL; Sichero L
Virology; 2016 May; 492():145-54. PubMed ID: 26945151
[TBL] [Abstract][Full Text] [Related]
44. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.
Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637
[TBL] [Abstract][Full Text] [Related]
45. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
Song S; Gulliver GA; Lambert PF
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
[TBL] [Abstract][Full Text] [Related]
47. Activation of telomerase by HPVs.
Katzenellenbogen RA
Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966
[TBL] [Abstract][Full Text] [Related]
48. The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway.
Cordano P; Gillan V; Bratlie S; Bouvard V; Banks L; Tommasino M; Campo MS
Virology; 2008 Aug; 377(2):408-18. PubMed ID: 18519144
[TBL] [Abstract][Full Text] [Related]
49. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
Liu X; Han S; Baluda MA; Park NH
Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
[TBL] [Abstract][Full Text] [Related]
50. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta enhances the ultraviolet-mediated stress response in p53-/- keratinocytes.
Merryman JI; Neilsen N; Stanton DD
Int J Oncol; 1998 Oct; 13(4):781-9. PubMed ID: 9735409
[TBL] [Abstract][Full Text] [Related]
52. E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.
Michel A; Kopp-Schneider A; Zentgraf H; Gruber AD; de Villiers EM
J Virol; 2006 Nov; 80(22):11153-64. PubMed ID: 16971438
[TBL] [Abstract][Full Text] [Related]
53. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
Demers GW; Foster SA; Halbert CL; Galloway DA
Proc Natl Acad Sci U S A; 1994 May; 91(10):4382-6. PubMed ID: 8183918
[TBL] [Abstract][Full Text] [Related]
54. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes.
Struijk L; van der Meijden E; Kazem S; Ter Schegget J; de Gruijl FR; Steenbergen RDM; Feltkamp MCW
J Gen Virol; 2008 Sep; 89(Pt 9):2303-2314. PubMed ID: 18753241
[TBL] [Abstract][Full Text] [Related]
55. [Non-melanoma skin cancers and human papillomavirus].
Aubin F; Humbey O; Guérrini JS; Mougin C; Laurent R
Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1131-8. PubMed ID: 14724516
[TBL] [Abstract][Full Text] [Related]
56. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis.
Hufbauer M; Cooke J; van der Horst GT; Pfister H; Storey A; Akgül B
Mol Cancer; 2015 Oct; 14():183. PubMed ID: 26511842
[TBL] [Abstract][Full Text] [Related]
58. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway.
Gaiotti D; Chung J; Iglesias M; Nees M; Baker PD; Evans CH; Woodworth CD
Mol Carcinog; 2000 Feb; 27(2):97-109. PubMed ID: 10657902
[TBL] [Abstract][Full Text] [Related]
59. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
60. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
